Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 4, 2014

Biogen and the National MS Society weigh in on the first reported death of an MS patient taking Tecfidera who developed PML.

  • Oral MS Medications
    /
October 30, 2014 Biogen Idec Inc., maker of the popular multiple sclerosis (MS) pill dimethyl fumarate (Tecfidera), announced the death…
Oral MS Medications

November 3, 2014

Wales First U.K. Country To Approve Cannabis-Based Medicine for MS Patients

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Welsh health minister Mark Drakeford has announced that Wales has become the first UK country to authorize a cannabis-based medicine…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 3, 2014

Neuroprotective Qualities of Masitinib Drug in Stroke Encouraging For MS Indication

  • MS Research Study and Reports
    /
An encouraging experimental drug that is being developed for Multiple Sclerosis continues to show promise in being able to offer neuroprotective benefits — an…
MS Research Study and Reports

November 1, 2014

Young adults most vulnerable to Multiple Sclerosis

  • MS Research Study and Reports
    /
CHANDIGARH: Young adults especially in the age group of 20-30 are the most vulnerable to Multiple Sclerosis (MS) but an…
MS Research Study and Reports

November 1, 2014

Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software

  • MS Genetic Research
    /
  • Multiple Sclerosis
    /
Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software…
MS Genetic Research

November 1, 2014

New iPad App Tracks MS Patient Course

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s…
Alternative therapies and devices for Multiple Sclerosis (MS)

October 31, 2014

Sanofi Recruiting for Teriflunomide ( AUBAGIO® ) Phase 4 Study

  • MS Research Study and Reports
    /
information showing below, was in-part obtained from the MSF Sanofi Recruiting for Teriflunomide Phase 4 Study Sanofi is seeking recruits…
MS Research Study and Reports

October 31, 2014

Researchers Discover Cognitive Shortcomings linked to PPMS

  • Multiple Sclerosis (MS) Symptoms
    /
In an MRI study of 26 patients with primary progressive multiple sclerosis, researchers discovered widespread cognitive abnormalities. They also found…
Multiple Sclerosis (MS) Symptoms

October 31, 2014

Help Push the Complex Rehab Bill Over the Finish Line!

  • For the Benefit of the Patient
    /
We’ve come a long way on an important federal bill that would help people with progressive MS and we can’t…
For the Benefit of the Patient

October 31, 2014

Multiple Sclerosis unit closure ‘will be devastating’

  • Healthcare Perspectives
    /
Closing Northern Ireland’s only dedicated respite centre will have a devastating impact on people with multiple sclerosis, a woman who…
Healthcare Perspectives

Categories

Latest Blog Posts